Feed Item (AI Text)
Title: Progress Update on SJP-002C: Advancing Towards a Breakthrough in Anti-Inflammatory Therapy for Upper Respiratory Infections, including COVID-19 | Sen-Jam Pharmaceutical
Canonical URL: https://wefunder.com/feed/171811
Published at: 2024-03-21 17:16:44 UTC
Updated at: 2025-07-16 21:27:41 UTC

Content summary:
Investors, Colleagues, and Friends, We have an update regarding our SJP-002C asset and are excited to share it with you. Frankly Speaking – SJP-002C Update Our Phase 2 clinical trial for SJP-002C, aimed at treating upper respiratory infections inc...

Key claims:
- Title: Progress Update on SJP-002C: Advancing Towards a Breakthrough in Anti-Inflammatory Therapy for Upper Respiratory Infections, including COVID-19 | Sen-Jam Pharmaceutical | citation: https://wefunder.com/feed/171811#claim-feed-item-title
- Published at: 2024-03-21 17:16:44 UTC | citation: https://wefunder.com/feed/171811#claim-feed-item-published-at

Author: Jim Iversen
Subject: Sen-Jam Pharmaceutical
Entity ID: wefunder:feed_item:171811